chr1-45566870-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000351829.9(AKR1A1):c.206C>T(p.Ala69Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,613,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000351829.9 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKR1A1 | NM_153326.3 | c.206C>T | p.Ala69Val | missense_variant, splice_region_variant | 4/9 | ENST00000351829.9 | NP_697021.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKR1A1 | ENST00000351829.9 | c.206C>T | p.Ala69Val | missense_variant, splice_region_variant | 4/9 | 1 | NM_153326.3 | ENSP00000312606 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000400 AC: 10AN: 250228Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135202
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461182Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726854
GnomAD4 genome AF: 0.000230 AC: 35AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 23, 2022 | The c.206C>T (p.A69V) alteration is located in exon 5 (coding exon 3) of the AKR1A1 gene. This alteration results from a C to T substitution at nucleotide position 206, causing the alanine (A) at amino acid position 69 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at